The trigger shot is the last IVF injection before egg retrieval. It mimics the LH surge that would normally cause ovulation, telling the follicles: ripen, and release in 36 hours. Egg retrieval is timed just before that release window closes.
For decades, the standard trigger was human chorionic gonadotropin (hCG) — brands like Ovidrel, Novarel, Pregnyl. Then, in the 2000s, researchers started using GnRH agonists (Lupron) as an alternative trigger in antagonist protocols. This unlocked a major safety advance.
How the Two Triggers Work
hCG trigger
hCG binds directly to LH receptors on granulosa cells, mimicking a natural LH surge. It's long-acting — the effect lasts 5–7 days. This creates sustained luteal support (good for the resulting pregnancy) but also prolongs the ovarian hyperstimulation window (bad for OHSS risk).
Lupron (GnRH agonist) trigger
Lupron acts on the pituitary rather than the ovary directly. It stimulates the pituitary to release a short, natural-like burst of FSH and LH. The effect resolves within about 24 hours — no sustained ovarian stimulation after retrieval.
The catch: Lupron trigger only works in antagonist protocols. In long agonist protocols, the pituitary is already suppressed and cannot respond to a Lupron trigger.
The OHSS Story
Ovarian hyperstimulation syndrome (OHSS) is IVF's most serious common complication. In severe cases: abdominal fluid accumulation, blood clots, kidney impairment, hospital admission. In its worst form, life-threatening.
Historically, moderate-to-severe OHSS occurred in 3–8% of IVF cycles. The single biggest risk factor is receiving hCG in a high-response cycle (many follicles, high estradiol). The hCG's long half-life sustains ovarian activity for a week after retrieval — right when OHSS symptoms peak.
Lupron trigger in antagonist protocols reduced severe OHSS to near-zero in appropriately selected patients. This is arguably the single largest safety improvement in IVF over the past 20 years.
The full safety strategy for high-OHSS-risk patients: antagonist protocol, Lupron trigger, freeze all embryos, transfer in a separate cycle. This decouples the retrieval cycle from pregnancy — no hCG exposure, no pregnancy hormones sustaining ovarian activity, minimal OHSS risk. Multiple large studies confirm this pathway effectively eliminates severe OHSS in high-risk patients.
Head-to-Head Decision Framework
| Factor | hCG Trigger | Lupron Trigger |
|---|---|---|
| Requires antagonist protocol | No | Yes |
| Duration of effect | 5–7 days | ~24 hours |
| Egg maturity yield | High (baseline) | Similar to hCG in most studies |
| OHSS risk | Elevated in high-response cycles | Near-zero |
| Luteal support | Built-in (via sustained hCG) | Requires enhanced progesterone/estrogen support |
| Fresh transfer viability | Standard | Compromised — best paired with freeze-all |
| Best fit for | Normal response, planning fresh transfer | High response, PCOS, prior OHSS, freeze-all cycles |
The Luteal Support Trade-off
Here's the honest complication with Lupron trigger: because it doesn't sustain ovarian hormone production the way hCG does, the corpus luteum can "lyse" (dissolve) early, causing low progesterone and estrogen after retrieval. If you're planning a fresh transfer, this is a problem — implantation and early pregnancy need robust hormonal support.
Solutions:
- Freeze-all + FET in separate cycle: cleanest solution. Skip fresh transfer entirely.
- Dual trigger: give both Lupron and a small dose of hCG (e.g. 1000–1500 IU) to get intermediate luteal support with reduced OHSS risk.
- Aggressive luteal support: high-dose progesterone and estradiol supplementation with fresh transfer.
The freeze-all approach has become common enough that many programs routinely do it for antagonist cycles regardless of OHSS risk. The evidence on fresh-vs-frozen transfer outcomes has been evolving, and for many patient categories, frozen embryo transfer is now considered equally effective or slightly better.
Egg Maturity Concerns
Early Lupron-trigger studies raised concerns about lower mature-egg (M2) yields. Subsequent data has largely resolved this — in properly-timed antagonist protocols with adequate LH exposure during stimulation, Lupron trigger produces mature egg yields equivalent to hCG.
Programs that use Lupron trigger routinely have generally worked out the protocol details. It's not automatic in less-experienced programs.
Practical Decisions by Patient Type
Standard responder, planning fresh transfer
hCG trigger is still standard. Low OHSS risk in normal responders makes the sustained hormonal support of hCG useful.
High responder, high AMH, PCOS
Lupron trigger + freeze-all is the safety-first standard of care in 2026. Do not accept an hCG trigger if you're high-response without a serious discussion of OHSS risk.
Prior OHSS history
Lupron trigger. Non-negotiable.
Poor responder
Depends on the program. Some use dual trigger (Lupron + low-dose hCG) to optimize both maturity and luteal support.
Fertility preservation (egg freezing)
Either — no fresh transfer means the luteal support question disappears. Lupron trigger is often preferred for safety.
Choosing an IVF clinic in Colombia?
Ask about their default trigger approach and OHSS prevention protocol. We can connect you with programs experienced in antagonist + Lupron trigger + freeze-all workflows for high-OHSS-risk patients.
Get Clinic Recommendations